Natixis Organon & Co. Transaction History

Natixis

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$10.95 - $17.32 $143,510 - $226,995	-13,106 Reduced 99.99%	1 $0
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $217,445 - $311,553	13,107 New	13,107 $227,000
Q4 2022 Feb 24, 2023	SELL	$23.31 - $28.61 $1.03 Million - $1.26 Million	-44,116 Reduced 71.09%	17,941 $501,000
Q4 2022 Feb 13, 2023	BUY	$23.31 - $28.61 $1.05 Million - $1.28 Million	44,868 Added 261.03%	62,057 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $144,027 - $210,808	6,155 Added 55.78%	17,189 $403,000
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $349,336 - $429,222	11,034 New	11,034 $372,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $4.36 Million - $5.42 Million	-152,171 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $4.33 Million - $5.78 Million	152,171 New	152,171 $4.6 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.